AnaptysBio Inc (ANAB) earnings · $1.62B cap
These earnings events as JSON? API free 100/dayAnaptysBio Inc (ANAB) is a biotechnology company listed on NASDAQ.
This ANAB earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported ANAB revenue for 2026-03-31 was $25.6M. Net income was -$52.9M. Revenue was down 66.5% from 2025-09-30 to 2026-03-31. ANAB currently screens at market cap $1.62B.
When the next ANAB 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 66.5% from 2025-09-30 to 2026-03-31. An earnings headline that ignores that move is noise.
Not investment advice. Full ANAB research stays on the stock page; the tape stays on the quote page.
ANAB earnings FAQ
What are ANAB's latest revenue and net income?
Latest cached AnaptysBio Inc (ANAB) revenue for Mar 31, 2026 was $25.6M. Net income was -$52.9M. Statements: https://lician.com/financials/anab
What is ANAB's latest diluted EPS?
Latest cached AnaptysBio Inc (ANAB) diluted EPS for Mar 31, 2026 was -$1.84.
What period does the latest ANAB earnings print cover?
The latest cached AnaptysBio Inc (ANAB) earnings print covers Mar 31, 2026. The prior cached period on this page is Sep 30, 2025.
How did ANAB revenue change from the prior cached period?
Cached AnaptysBio Inc (ANAB) revenue was down 66.5% from $76.3M (Sep 30, 2025) to $25.6M (Mar 31, 2026). Statements: https://lician.com/financials/anab
Where are ANAB earnings listed?
Cached earnings facts for AnaptysBio Inc (ANAB) are listed at https://lician.com/earnings/anab. Statements: https://lician.com/financials/anab
Not investment advice.